Breaking News, Promotions & Moves

Gannet BioChem Fills Key Executive Leadership Positions

Names Nicholas Shackley as CEO; Chris Edwards as CFO; and Dr. Tony Sander as COO.

Nicholas Shackley, CEO.

Gannet BioChem, a specialty chemical Contract Development and Manufacturing Organization (CDMO), has appointed several key executives following its recent acquisition by Ampersand Capital Partners.

The new leadership team includes:

  • Nicholas Shackley as Chief Executive Officer
  • Chris Edwards as Chief Financial Officer
  • Dr. Tony Sander as Chief Operating Officer

“These leadership appointments mark an exciting new chapter for Gannet BioChem as an independent company,” said Melanie Fan, Principal at Ampersand Capital Partners. “We are thrilled to welcome Nick and Chris to the leadership team, while continuing to collaborate with Tony in his expanded role. With their expertise and vision, this team is well-positioned to drive innovation and growth, strengthening our commitment to advancing biopharmaceutical and therapeutic products.”

Nick Shackley, CEO

As the newly appointed CEO of Gannet BioChem, Shackley brings over 25 years of experience in pharmaceuticals and chemical manufacturing.

His leadership is defined by a strong focus on business transformation, operational efficiency, and commercial growth. Previously, he served as Senior Vice President and Chief Commercial Officer at Lupin Manufacturing Solutions, where he led sales, business development, strategic marketing, and product management. Shackley also played a pivotal role in expanding market share and implementing strategic initiatives in executive positions at Veranova, BASF, Cambrex, and Aceto Corporation.

His expertise in global business strategy within life sciences manufacturing will be instrumental in driving Gannet BioChem’s continued success.

Chris Edwards, CFO

An experienced financial executive, Edwards was previously CFO at Solesis and has held global finance operations roles at Syneos Health, Convatec, and Bristol-Myers Squibb.

Dr. Tony Sander, COO

A key leader at Gannet BioChem since 2003, Sander has over 30 years of experience in chemical and API manufacturing, overseeing manufacturing and site operations at the Huntsville, AL facility.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters